Neurodegenerative Cascade A Part of Alzheimer's Illness - Multifactorial Dissection in Amyloidopathy, Tauopathy, And Neuroinflammatory Crosstalk

The primary cause of dementia, Alzheimer's disease (AD) is a progressive neurological illness marked by behavioral abnormalities, memory loss, and cognitive decline. Amyloid-beta (Aβ) plaques and hyper phosphorylated tau tangles are the main pathophysiological components of AD, resulting in synaptic dysfunction, oxidative stress, and neuronal death. While the specific cause remains unclear, various ideas have been presented, including the amyloid cascade, tau pathology, oxidative stress, cholinergic dysfunction, glutamate excitotoxicity, inflammation, and mitochondrial dysfunction. The start and course of illness are also influenced by environmental and genetic risk factors, including the APOE ε4 allele, age, food, physical inactivity, smoking, diabetes, and hypertension. Together with neuroimaging methods, biomarkers including Aβ42, total tau, and phosphorylated tau levels in CSF fluid are essential for early diagnosis and follow-up. Cholinesterase inhibitors and NMDA receptor antagonists, such as donepezil and memantine, are the mainstays of current therapy, which alleviate symptoms. New treatment strategies focus on neuroinflammation, tau aggregation, Aβ generation, and synaptic repair. A proven cure or extremely successful disease-modifying medication is still elusive after decades of study. There is promise for early intervention and disease control because to ongoing clinical studies and biomarker developments.